| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/19/2002 | EP1214335A1 Gamma-carboxyglutamate containing conopeptides |
| 06/19/2002 | EP1214333A2 Stabilized soluble glycoprotein trimers |
| 06/19/2002 | EP1214098A1 Capsid-modified recombinant adenovirus and methods of use |
| 06/19/2002 | EP1214097A1 Nucleic acids encoding polyepitope polypeptides |
| 06/19/2002 | EP1214090A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214088A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 06/19/2002 | EP1213956A1 Seedless fruit production |
| 06/19/2002 | EP1164838A4 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
| 06/19/2002 | EP0977846B1 Neuronal mort1 isoforms |
| 06/19/2002 | EP0946198B1 Method of stabilizing troponin I (cTnI) via conjugation with an active polymer |
| 06/19/2002 | EP0900275B1 Methods and reagents for modulating apoptosis |
| 06/19/2002 | EP0892643B1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 06/19/2002 | EP0870050B1 Toxic-protein expressing viruses and producer cell lines |
| 06/19/2002 | EP0859841B1 Protein/(poly)peptide libraries |
| 06/19/2002 | EP0854920A4 Mouse integrin subunits |
| 06/19/2002 | EP0812421B1 Anti dna antibody detection involving telomeric dna sequence recognition and binding |
| 06/19/2002 | EP0804616B1 Specific and universal amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 06/19/2002 | EP0714510B1 Natural killer cell-specific antigen and antibodies that identify the same |
| 06/19/2002 | EP0632817B1 Neurotrophic factors having altered receptor binding specificities |
| 06/19/2002 | EP0625204B1 Hepatitis therapeutics |
| 06/19/2002 | EP0611397B1 Feline leukemia virus vaccines |
| 06/19/2002 | EP0462215B1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 06/19/2002 | CN1354800A Recombinant newcastle disease virus RNA expression systems and vaccines |
| 06/19/2002 | CN1354796A Medical preparations for treatment of alpha-galactosidase A deficiency |
| 06/19/2002 | CN1354793A i(NAC1)-plant gene encoding transcription factor involved in cotyledon and lateral root development |
| 06/19/2002 | CN1354792A Biosynthesis of foreign proteins using transformed microalgae |
| 06/19/2002 | CN1354791A Compositions for treatment and diagnosis of breast cancer and methods for their use |
| 06/19/2002 | CN1354790A Transformant for screening of inhibitors for human immunodeficiency virus |
| 06/19/2002 | CN1354788A Cyclic peptides |
| 06/19/2002 | CN1354787A Process for purifying human papillomavirus virus-like particles |
| 06/19/2002 | CN1354756A MEG-4 protein |
| 06/19/2002 | CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/19/2002 | CN1354675A Adjuvant combination formulations |
| 06/19/2002 | CN1354674A Synthetic peptide vaccines for foot-and-mouth disease |
| 06/19/2002 | CN1354671A Method for inhibition of phospholamban activity for treatment of cardiac disease and heart failure |
| 06/19/2002 | CN1354668A Isolated peptides which bind to HLA-B35 molecules |
| 06/19/2002 | CN1354186A Preparation method of recombinant human vascular endothelial cytopoiesis suppressor factor with human LgG1Fc fragment molecular structure and application of its product |
| 06/19/2002 | CN1354185A A novel polypeptide-Krev-1/rapla conjugated protein KRIT 134.87 and polynucleotide coding said polypeptide |
| 06/19/2002 | CN1354183A Tumor death induction ligand gene, gene expression protein and its preparation method |
| 06/19/2002 | CN1086421C Synthesis and clone of composite polyvalent vaccine gene for type-C hepatitis virus |
| 06/18/2002 | US6407315 Transcription in seeds and promoters of polynucleosides |
| 06/18/2002 | US6407314 Purified dna sequences |
| 06/18/2002 | US6407313 Altering biomass partitioning in a plant, linking a promoter and introducing said vector into a plant |
| 06/18/2002 | US6407312 Transgenic plant cells and vectors with cultures |
| 06/18/2002 | US6407222 Purified dna molecule codes |
| 06/18/2002 | US6407221 Chimeric chains for receptor-associated signal transduction pathways |
| 06/18/2002 | US6407216 Vertebrate smoothened antibodies |
| 06/18/2002 | US6407213 Method for making humanized antibodies |
| 06/18/2002 | US6407212 Method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions |
| 06/18/2002 | US6407211 Dendroaspis(green mamba snake) natriuretic peptide has at least one activity selected from the group consisting of vasodilation, antriuresis, diuresis and renin-suppressing activity |
| 06/18/2002 | US6407210 Nematode neuromuscular junction GABA receptors and methods related thereto |
| 06/18/2002 | US6407209 Interferon-induced human protein in pure form, monoclonal antibodies thereto and test kits containing these antibodies |
| 06/18/2002 | US6407207 Amino acid sequences of proteins |
| 06/18/2002 | US6407205 Increasing fertility of vertibrates by administering lamprey luteinizing hormone releasing factor ii |
| 06/18/2002 | US6407203 Cytochrome c and polynucleotides encoding cytochrome c |
| 06/18/2002 | US6407063 Tumor antigens and CTL clones isolated by a novel procedure |
| 06/18/2002 | US6407062 Polypeptide; antiproliferative agent |
| 06/18/2002 | US6407060 Method for enhancing functional recovery following central nervous system ischemia or trauma |
| 06/18/2002 | US6407059 Conformationally constrained backbone cyclized peptide analogs |
| 06/18/2002 | US6406917 Enhancing sensitivity of tumor cells in chemotherapy |
| 06/18/2002 | US6406908 Vanilloid receptor |
| 06/18/2002 | US6406907 Nucleotide sequences, codes and polypeptides |
| 06/18/2002 | US6406902 Herpes virus proteinase and methods of assaying |
| 06/18/2002 | US6406900 Flea protease proteins, nucleic acid molecules and uses thereof |
| 06/18/2002 | US6406897 Modified protein with improved stability coupled to glycan |
| 06/18/2002 | US6406889 509hk |
| 06/18/2002 | US6406888 Cytokines, transcription, dna segments and termination |
| 06/18/2002 | US6406887 Antigens for binding to antibodies in tissues |
| 06/18/2002 | US6406886 Isolated dna codes for cell division mechanism controlling proteins, dna hybridize with nucleotide sequences |
| 06/18/2002 | US6406885 Plant cell transformation vectors and dna code intimin |
| 06/18/2002 | US6406884 Isolated nucleic acid sequence of cdna insert of plasmid |
| 06/18/2002 | US6406883 Lmb gene of Streptococcus agalactiae |
| 06/18/2002 | US6406872 Nematode neuromuscular junction GABA receptors and methods related thereto |
| 06/18/2002 | US6406871 Method for detecting ligand binding to G protein coupled receptors |
| 06/18/2002 | US6406870 Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes |
| 06/18/2002 | US6406868 AMPA-binding human GluR1 receptors |
| 06/18/2002 | US6406867 Binding antibodies and proteins |
| 06/18/2002 | US6406866 Competitive binding to mammalian methadone specific opiod receptors in cell expression |
| 06/18/2002 | US6406864 By contacting the sample with a binding partner which binds the first protein conformation but not the second disease related conformation; proteins such as prions, amyloids, human transthyretin |
| 06/18/2002 | US6406861 Viral diseases and immunogens |
| 06/18/2002 | US6406859 DNA encoding a 5-HT 1F receptor and uses thereof |
| 06/18/2002 | US6406855 Detection of cytokines and nucleic acid subsequences of polynucleotides and injections |
| 06/18/2002 | US6406841 Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides |
| 06/18/2002 | US6406704 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/18/2002 | US6406700 Antigrowth agents for cancer, heat shock proteins bonding to proteins, complexes |
| 06/18/2002 | US6406698 Pharmaceutical composition comprising serum amyloid P component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components |
| 06/18/2002 | US6406697 Amino acid sequence of ligand binding partner protein fused to c-terminus to n-terminus of immunoglobulin and cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods. |
| 06/18/2002 | US6406696 Activation of t cells, immunopotentiation and immunology, administering anti-cd3 monoclonal antibodies |
| 06/18/2002 | US6406679 Use of HL-60-related lectins in drug delivery and detection of lectin-expressing cells |
| 06/18/2002 | CA2185098C Fk506 binding protein gene |
| 06/18/2002 | CA2098819C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions |
| 06/18/2002 | CA2091907C Stable propagation of modified full length cystic fibrosis transmembrane conductance regulator protein cdna in heterologous systems |
| 06/18/2002 | CA2034611C Synthetic peptide compositions with immunoreactivities to antibodies to htlv |
| 06/18/2002 | CA2025566C Method for the determination of pathogenic listeria bacteria |
| 06/18/2002 | CA2025019C Synthetic peptide compositions with immunoreactivities to antibodies to htlv-1 |
| 06/18/2002 | CA1341369C Human interferon-.beta.2a and interferon-.beta.2b; vectors containing genes coding for said interferons: cell lines producing same and use of said interferons as pharmaceuticals |
| 06/13/2002 | WO2002046768A2 Proteins, genes and their use for diagnosis and treatment of chronic asthma |
| 06/13/2002 | WO2002046767A2 Diagnosis and treatment of alzheimer's disease |
| 06/13/2002 | WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer |